Center for Advanced Robotic & Laparoscopic Surgery, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA.
J Urol. 2012 Mar;187(3):807-14. doi: 10.1016/j.juro.2011.10.146. Epub 2012 Jan 15.
We present a novel concept of zero ischemia anatomical robotic and laparoscopic partial nephrectomy.
Our technique primarily involves anatomical vascular microdissection and preemptive control of tumor specific, tertiary or higher order renal arterial branch(es) using neurosurgical aneurysm micro-bulldog clamps. In 58 consecutive patients the majority (70%) had anatomically complex tumors including central (67%), hilar (26%), completely intrarenal (23%), pT1b (18%) and solitary kidney (7%). Data were prospectively collected and analyzed from an institutional review board approved database.
Of 58 cases undergoing zero ischemia robotic (15) or laparoscopic (43) partial nephrectomy, 57 (98%) were completed without hilar clamping. Mean tumor size was 3.2 cm, mean ± SD R.E.N.A.L. score 7.0 ± 1.9, C-index 2.9 ± 2.4, operative time 4.4 hours, blood loss 206 cc and hospital stay 3.9 days. There were no intraoperative complications. Postoperative complications (22.8%) were low grade (Clavien grade 1 to 2) in 19.3% and high grade (Clavien grade 3 to 5) in 3.5%. All patients had negative cancer surgical margins (100%). Mean absolute and percent change in preoperative vs 4-month postoperative serum creatinine (0.2 mg/dl, 18%), estimated glomerular filtration rate (-11.4 ml/minute/1.73 m(2), 13%), and ipsilateral kidney function on radionuclide scanning at 6 months (-10%) correlated with mean percent kidney excised intraoperatively (18%). Although 21% of patients received a perioperative blood transfusion, no patient had acute or delayed renal hemorrhage, or lost a kidney.
The concept of zero ischemia robotic and laparoscopic partial nephrectomy is presented. This anatomical vascular microdissection of the artery first and then tumor allows even complex tumors to be excised without hilar clamping. Global surgical renal ischemia is unnecessary for the majority of patients undergoing robotic and laparoscopic partial nephrectomy at our institution.
我们提出了一种新的零缺血解剖性机器人辅助和腹腔镜肾部分切除术的概念。
我们的技术主要涉及解剖性血管显微解剖,并使用神经外科动脉瘤微夹预先控制肿瘤特异性的三级或更高一级的肾动脉分支。在 58 例连续患者中,大多数(70%)的肿瘤解剖结构复杂,包括中央型(67%)、肾门型(26%)、完全位于肾内型(23%)、pT1b 型(18%)和孤立肾(7%)。数据从机构审查委员会批准的数据库中前瞻性收集和分析。
在 58 例接受零缺血机器人(15 例)或腹腔镜(43 例)肾部分切除术的患者中,57 例(98%)在不进行肾门夹闭的情况下完成手术。平均肿瘤大小为 3.2cm,平均±SD R.E.N.A.L. 评分 7.0±1.9,C 指数 2.9±2.4,手术时间 4.4 小时,出血量 206cc,住院时间 3.9 天。无术中并发症。术后并发症(22.8%)为低级别(Clavien 分级 1-2 级)19.3%,高级别(Clavien 分级 3-5 级)3.5%。所有患者均获得阴性肿瘤切缘(100%)。术前与术后 4 个月的血清肌酐绝对值和百分比变化(0.2mg/dl,18%)、估算肾小球滤过率(-11.4ml/min/1.73m2,13%)以及 6 个月时放射性核素扫描的同侧肾脏功能(-10%)与术中切除肾脏的平均百分比(18%)相关。尽管 21%的患者接受了围手术期输血,但无患者发生急性或迟发性肾出血或肾脏丢失。
提出了零缺血机器人辅助和腹腔镜肾部分切除术的概念。这种动脉的解剖性血管显微解剖,然后是肿瘤的解剖性血管显微解剖,使得即使是复杂的肿瘤也可以在不进行肾门夹闭的情况下切除。在我们的机构中,大多数接受机器人辅助和腹腔镜肾部分切除术的患者不需要进行全球外科肾缺血。